BlackRock Advisors’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $519K | Buy |
39,187
+1,205
| +3% | +$16K | ﹤0.01% | 2133 |
|
|
2016
Q3 | $900K | Sell |
37,982
-59,808
| -61% | -$1.42M | ﹤0.01% | 1825 |
|
|
2016
Q2 | $2.82M | Buy |
97,790
+1,960
| +2% | +$56.5K | ﹤0.01% | 1282 |
|
|
2016
Q1 | $3.07M | Buy |
95,830
+65,853
| +220% | +$2.11M | ﹤0.01% | 1245 |
|
|
2015
Q4 | $1.28M | Sell |
29,977
-14,561
| -33% | -$623K | ﹤0.01% | 1578 |
|
|
2015
Q3 | $1.57M | Sell |
44,538
-1,509
| -3% | -$53.1K | ﹤0.01% | 1420 |
|
|
2015
Q2 | $2.11M | Buy |
46,047
+2,720
| +6% | +$125K | ﹤0.01% | 1215 |
|
|
2015
Q1 | $2.03M | Buy |
43,327
+6,015
| +16% | +$282K | ﹤0.01% | 1191 |
|
|
2014
Q4 | $1.18M | Sell |
37,312
-1,912
| -5% | -$60.6K | ﹤0.01% | 1375 |
|
|
2014
Q3 | $930K | Sell |
39,224
-911
| -2% | -$21.6K | ﹤0.01% | 1449 |
|
|
2014
Q2 | $1.2M | Sell |
40,135
-5,922
| -13% | -$178K | ﹤0.01% | 1351 |
|
|
2014
Q1 | $1.22M | Buy |
46,057
+2,047
| +5% | +$54.1K | ﹤0.01% | 1386 |
|
|
2013
Q4 | $1.11M | Buy |
44,010
+3,444
| +8% | +$86.6K | ﹤0.01% | 1432 |
|
|
2013
Q3 | $830K | Buy |
40,566
+192
| +0.5% | +$3.93K | ﹤0.01% | 1526 |
|
|
2013
Q2 | $805K | Buy |
+40,374
| New | +$805K | ﹤0.01% | 1490 |
|